» Articles » PMID: 37192799

Clinical Characteristics of Locomotive Syndrome Categorised by the 25-question Geriatric Locomotive Function Scale: a Systematic Review

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 May 16
PMID 37192799
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to compile the currently available evidence on the clinical characteristics of the locomotive syndrome (LS) categorised by the 25-question Geriatric Locomotive Function Scale (GLFS-25) and clarify its clinical usefulness for assessing mobility function.

Design: Systematic review.

Data Sources: The PubMed and Google Scholar were searched for the relevant studies on 20 March 2022.

Eligibility Criteria: We included relevant peer-reviewed articles, available in English language, on clinical LS characteristics categorised with the GLFS-25.

Data Extraction And Synthesis: Pooled ORs or mean differences (MDs) of the LS groups were calculated and compared with the non-LS groups for each clinical characteristic.

Results: In total, 27 studies that involve 13 281 participants (LS, n=3385; non-LS, n=9896) were examined in this analysis. Older age (MD 4.71; 95% (CI) 3.97 to 5.44; p<0.00001), female gender (OR 1.54; 95% CI 1.38 to 1.71; p<0.00001), higher body mass index (MD 0.78; 95% CI 0.57 to 0.99; p<0.00001), osteoporosis (OR 1.68; 95% CI 1.32 to 2.13; p<0.0001), depression (OR 3.14; 95% CI 1.81 to 5.44; p<0.0001), lower lumbar lordosis angle (MD -7.91; 95% CI -10.08 to -5.74; p<0.00001), higher spinal inclination angle (MD 2.70; 95% CI 1.76 to 3.65; p<0.00001), lower grip strength (MD -4.04; 95% CI -5.25 to -2.83; p<0.00001), lower back muscle strength (MD -15.32; 95% CI -23.83 to -6.81; p=0.0004), lower maximum stride (MD -19.36; 95% CI -23.25 to -15.47; p<0.00001), higher timed up-and-go (MD 1.36; 95% CI 0.92 to 1.79; p<0.00001), lower one-leg standing time (MD -19.13; 95% CI -23.29 to -14.97; p<0.0001) and slower normal gait speed (MD -0.20; 95% CI -0.22 to -0.18; p<0.0001) were found to be associated with LS. No significant differences were noted in other clinical characteristics between the two groups.

Conclusions: GLFS-25 is clinically useful for assessing mobility function according to the evidence available on the clinical characteristics of LS categorised by the GLFS-25 questionnaire items until.

Citing Articles

Relationship between physical activity and locomotive syndrome among young and middle-aged Japanese workers.

Watanabe K, Lu X, Masuda S, Miyamoto T, Katoh T J Occup Health. 2024; 66(1.

PMID: 38192224 PMC: 10878362. DOI: 10.1093/joccuh/uiae001.


Phytochemicals and Vitamin D for a Healthy Life and Prevention of Diseases.

Santa K, Watanabe K, Kumazawa Y, Nagaoka I Int J Mol Sci. 2023; 24(15).

PMID: 37569540 PMC: 10419318. DOI: 10.3390/ijms241512167.

References
1.
Nakamura M, Hashizume H, Oka H, Okada M, Takakura R, Hisari A . Physical Performance Measures Associated With Locomotive Syndrome in Middle-Aged and Older Japanese Women. J Geriatr Phys Ther. 2015; 38(4):202-7. DOI: 10.1519/JPT.0000000000000033. View

2.
Nishimura A, Ito N, Asanuma K, Akeda K, Ogura T, Sudo A . Do exercise habits during middle age affect locomotive syndrome in old age?. Mod Rheumatol. 2017; 28(2):334-338. DOI: 10.1080/14397595.2017.1333670. View

3.
Kobayashi T, Morimoto T, Shimanoe C, Ono R, Otani K, Mawatari M . Development of a simple screening tool based on the 5-question geriatric locomotive function scale for locomotive syndrome. J Orthop Sci. 2021; 27(4):913-920. DOI: 10.1016/j.jos.2021.05.001. View

4.
Nakamura M, Hashizume H, Nomura S, Kono R, Utsunomiya H . The Relationship between Locomotive Syndrome and Depression in Community-Dwelling Elderly People. Curr Gerontol Geriatr Res. 2017; 2017:4104802. PMC: 5396418. DOI: 10.1155/2017/4104802. View

5.
Imagama S, Ando K, Kobayashi K, Machino M, Tanaka S, Morozumi M . Differences of locomotive syndrome and frailty in community-dwelling middle-aged and elderly people: Pain, osteoarthritis, spinal alignment, body balance, and quality of life. Mod Rheumatol. 2019; 30(5):921-929. DOI: 10.1080/14397595.2019.1665616. View